We are pioneering an advanced, minimally invasive, comprehensive epigenomics platform with the potential to profoundly impact the research and development of new medicines and the use of approved medicines in clinical practice across a number of conditions, including cancer. $125,000 - $175,000 a year Scientist I/II: $1250,000 - $150,000 Senior Scientist: $150,000 - $175,000 Final compensation will be based on a candidate’s qualifications, experience, and geographic location.